Get complete access to comprehensive company data for Ranbiosis Pharmaceutical Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Ranbiosis Pharmaceutical Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 1.00 lakh
₹ 0.10 lakh
21 Jul 2022
31 Mar 2024
Ranbiosis Pharmaceutical Private Limited is an Indian private limited company incorporated on 21 Jul 2022. The company's registered office is situated in Bangaluru, Karnataka, India.
The current status of Ranbiosis Pharmaceutical Private Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2024 (FY 2023-2024).
Ranbiosis Pharmaceutical Private Limited is a company limited by shares with an authorized capital of ₹1.00 lakh and a paid-up capital of ₹0.10 lakh as per the records maintained by the Ministry of Corporate Affairs (MCA).
Ranbiosis Pharmaceutical Private Limited has 3 directors. The directors of the company include Suruchi Kumari, Mohammad Akhtar Jamal, Choudhary Santanu Kumar.
The registered office of Ranbiosis Pharmaceutical Private Limited is located at 101-132,P T Complex C.N.Halli, R.T Nagar Bengaluru Karnataka 560032 India in Bangaluru, Karnataka, India.
- CIN/LLPIN/FCRN: U24290KA2022PTC164094
- Legal Name: Ranbiosis Pharmaceutical Private Limited
- ROC Code: Roc Bangalore
- Company No.: 164094
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Private
- Listing Status: Unlisted
- Industry: Manufacture Of Chemicals And Chemical Products
- Date of AGM: 30 Sep 2024
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Ranbiosis Pharmaceutical Private Limited |
|---|
Frequently Asked Questions
- choudhary santanu kumar
- mohammad akhtar jamal
- suruchi kumari